Karbamazepin Tillomed

Carbamazepine, the active ingredient in Karbamazepin Tillomed, is an anticonvulsant presented as an oral formulation for systemic use. It is employed to control certain seizure types, relieve facial nerve pain, and is sometimes used off‑label for mood stabilization.

GNH USA supplies Karbamazepin Tillomed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Carbamazepine acts on neuronal excitability and is indicated for several neurological and psychiatric conditions.

- Epilepsy (partial seizures): reduces the frequency and severity of focal seizures. - Trigeminal neuralgia: alleviates severe facial pain episodes associated with the trigeminal nerve. - Bipolar disorder (off‑label): may help stabilize mood swings in some patients.

Carbamazepine may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Drowsiness: increased sleepiness or fatigue. - Nausea: upset stomach often accompanied by loss of appetite. - Blurred vision: temporary visual disturbances.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin rash with mucosal involvement. - Aplastic anemia: marked reduction in blood cell production. - Hepatic failure: significant liver dysfunction. - Agranulocytosis: dangerous drop in white blood cell count.

Before initiating therapy, clinicians should evaluate several safety considerations.

- Pregnancy: Category D – use only if benefits outweigh risks. - Liver function: monitor hepatic enzymes regularly. - Blood counts: periodic CBC to detect hematologic abnormalities. - Concomitant CNS depressants: may enhance drowsiness and sedation. - Discontinuation: taper gradually to avoid withdrawal seizures. - Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture.

Carbamazepine influences and is influenced by several other medicines.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - Strong CYP3A4 inhibitors (e.g., itraconazole, clarithromycin): may increase carbamazepine levels.

Moderate Interactions (Monitor Closely): - Oral contraceptives: reduced efficacy, consider alternative contraception. - Anticoagulants (e.g., warfarin): may require dose adjustment. - Other antiepileptics (e.g., phenobarbital): additive CNS depression. - Antidepressants (e.g., bupropion): may lower seizure threshold.